Evidence map›Paper›PMID 35864146›Full record

ArticleEuropean journal of human genetics : EJHG2022

The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis.

Kristiana Salmon, Jay P Ross, Vanessa Bertone, Maria Gobbo, Nancy Anoja, Jason Karamchandani, Patrick A Dion, Guy A Rouleau, Angela Genge

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of human genetics : EJHG, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Observational
  4. Localization of Potential Energy in Hydrogen Bonds of theInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. A report of resources used by clinicians in the UK to support motor neuron disease genomic testing.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2024
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kristiana SalmonDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. Kristiana.salmon@mcgill.ca.ORCID http://orcid.org/0000-0002-0013-5568
Jay P RossMontreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.ORCID http://orcid.org/0000-0002-8183-2524
Vanessa BertoneDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Maria GobboDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Nancy AnojaDepartment of Medical Genetics, McGill University Health Centre, Montreal, QC, Canada.
Jason KaramchandaniMontreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
Patrick A DionDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
Guy A RouleauDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.ORCID http://orcid.org/0000-0001-8403-1418
Angela GengeDepartment of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.

Funding

CIHR FRN 159279
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amyotrophic Lateral SclerosisAtaxin-2C9orf72 ProteinDNA Repeat ExpansionGenetic Association StudiesHumansTrinucleotide Repeat ExpansionAtaxin-2ATXN2 protein, humanC9orf72 Protein

Identifiers

PMID35864146
PMCPMC9626461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.